(Press-News.org) Osaka, Japan – Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss drugs, doing away with injections in favor of a one-time treatment.
In a study due to be published in Communications Medicine, researchers from The University of Osaka have revealed that a modified genome editing approach to tackle noncommunicable, multifaceted diseases. The approach introduced a new protein-coding gene, rather than attempting to correct a mutation in an existing gene and could be the key to lifelong effective weight management.
Genome editing is a cutting-edge treatment approach that works by correcting genetic mutations that cause disease. However, it is less effective for conditions that aren’t caused by a single mutation, like heart disease, diabetes, and obesity. As these are some of the leading causes of mortality, the research aimed to discover how gene therapy can provide therapeutic gain in these diseases.
“An alternative to genome editing for many complex and non-genetic diseases is biologic medications, which are essentially injectable proteins,” says senior author of the study Keiichiro Suzuki. “These medications do not stay in the body long, meaning they typically have to be injected weekly, or even daily, to maintain consistent therapeutic levels of the drug.”
To reduce the need for constant injections, the researchers developed an approach combining genome editing with biologics. They introduced a gene that encodes Exenatide, a weight-loss medication that acts as a glucagon-like peptide-1 receptor agonist, into mice with obesity and pre-diabetes. They then monitored Exenatide levels in the blood, as well as weight and food intake, over the next few months.
“The results were very exciting,” explains Suzuki. “We found that these genome-edited mice produced high levels of Exenatide that could be detected in blood for several months after introduction of the gene.”
Introducing the gene into the mice encouraged the liver cells to continue producing Exenatide, creating a ‘reservoir’ of the medication in the liver. This reservoir ensured there was a steady flow of Exenatide in the bloodstream, as shown in the research findings.
In addition, the treated mice ate less food and gained less weight than normal mice whose genomes were not edited. Equally, the genome-edited mice being able to produce their own Exenatide improved their glucose metabolism and insulin sensitivity, key factors in controlling diabetes symptoms, without any noticeable side effects.
“We hope that our design of a one-time genetic treatment can be applied to many conditions that do not have exact genetic causes,” says Suzuki.
This innovative approach could be an alternative to standard genome editing, which is unable to treat diseases like Type 2 diabetes and chronic inflammatory conditions. Enabling sustained in-body drug production could shorten treatment time, improve treatment adherence, and raise the quality of life for many patients.
###
The article, “Targeted In Vivo Gene Integration of a Secretion-Enabled GLP-1 receptor agonist Reverses Diet-induced Non-genetic Obesity and Pre-diabetes,” will be published in Communications Medicine at DOI: https://doi.org/10.1038/s43856-025-00959-8.
About The University of Osaka
The University of Osaka was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
END
A new study, led by experts at the University of Nottingham, provides the strongest evidence to date that cancer is extremely rare in turtles, a finding that could offer valuable clues for preventing or fighting cancer in humans.
While previous research had hinted that cancer might be uncommon in turtles, the new analysis, published in BioScience, shows that only about 1% of individuals are affected, far less than in mammals or birds. The study was led by Dr Ylenia Chiari from the School of Life Sciences ...
In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer. What would normally take decades for a scientist to create – a custom-made protein for a particular disease – can now be done in seconds.
For the first time, Australian scientists have used Artificial Intelligence (AI) to generate a ready-to-use biological protein, in this case, one that can kill antibiotic resistant bacteria like E. coli.
This ...
Researchers at Princeton University and the Simons Foundation have identified four clinically and biologically distinct subtypes of autism, marking a transformative step in understanding the condition’s genetic underpinnings and potential for personalized care.
Analyzing data from over 5,000 children in SPARK, an autism cohort study funded by the Simons Foundation, the researchers used a computational model to group individuals based on their combinations of traits. The team used a “person-centered” approach that considered a broad range of over 230 traits in each individual, from social interactions to repetitive behaviors to developmental ...
New York, NY [July 9, 2025]—A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how doctors determine the best treatment for cancer patients—by enhancing how tumor samples are analyzed in the lab.
The findings, published in the July 9 online edition of Nature Medicine https://www.nature.com/articles/s41591-025-03780-x, showed that AI can accurately predict genetic mutations from routine pathology slides—potentially reducing the need for rapid genetic testing in certain cases.
“Our ...
CAMBRIDGE, MA -- For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is injecting a hormone called glucagon.
As an emergency backup, for cases where patients may not realize that their blood sugar is dropping to dangerous levels, MIT engineers have designed an implantable reservoir that can remain under the skin and be triggered to release glucagon when blood sugar levels get too low.
This approach could also help in cases ...
When the Empire State Building was constructed, its 102 stories rose above midtown one piece at a time, with each individual element combining to become, for 40 years, the world’s tallest building. Uptown at Columbia, Oleg Gang and his chemical engineering lab aren’t building Art Deco architecture; their landmarks are incredibly small devices built from nanoscopic building blocks that arrange themselves.
“We can build now the complexly prescribed 3D organizations from self-assembled nanocomponents, a kind of nanoscale version of ...
Autism is classified as a ‘spectrum’ for a reason: Each case is different. Scientists have struggled to parse through the many ways autism can manifest, much less to link these varying observable traits (called phenotypes) to underlying genetics.
A new study in Nature Genetics from researchers at the Flatiron Institute’s Center for Computational Biology (CCB) and their collaborators leverages data from SPARK, the largest-ever study of autism, to analyze phenotypic and genotypic data from more than 5,000 participants with autism ...
A new paper published in Nature Communications reveals how the way tree species are arranged in a forest can help optimise ecosystem functioning and productivity. The study was conducted using empirical field data combined with advanced computer models and simulations by researchers at the German Centre for Integrative Biodiversity Research (iDiv), Leipzig University, Friedrich Schiller University Jena, and the French National Centre for Scientific Research (CNRS).
The researchers simulated virtual forests with multiple arrangements of tree species, such as block ...
Researchers have identified how thyroxine, a human thyroid hormone, can positively influence the life-critical calcification in soft corals, and have developed a unique technique for injecting molecules into coral tissues.
“We understand a lot about hormones in vertebrates, but much less about hormones in invertebrate animals such as corals,” says Clémence Forin, a PhD student at the Scientific Centre of Monaco. “We wanted to learn more about how they process hormones to find out how they are involved into the calcification process.”
A major barrier to researching the role and regulation of ...
Research into the intestinal cells of Burmese pythons has revealed the existence of a previously unknown cell type, responsible for completely absorbing the skeletons of their prey.
Most carnivores eat only the flesh of their prey and avoid eating the bones or pass them undigested, but many snakes and reptiles often consume their prey whole, including the bones. The cellular mechanisms that enable them to do this have remained mysterious until now.
Snakes that are fed on boneless prey suffer from calcium deficiencies, and so bones are a required part of their diet. However, absorbing all the available calcium from a skeleton could ...
